AI English summary of an SEC filing — figures as filed
Leidos LDOSThe company said net bookings were approximately $8.1 billion and $15.8 billion for the 3-month and 9-month periods ended September 27, 2024, compared with $7.9 billion and $13.8 billion in the prior-year periods.
Key points
AI summaryThe company said net bookings were approximately $8.1 billion and $15.8 billion for the 3-month and 9-month periods ended September 27, 2024, compared with $7.9 billion and $13.8 billion in the prior-year periods.
The company cited an increase in operating income for Commercial & International over the 3 months, attributing it to the impairment charges of $679 million recorded in the prior year. For the 9-month period, it also cited the same impairment charges, program wins and a net increase in volumes, and said these were partially offset by write-downs on certain programs within its UK operations.
The company said its effective tax rate was 23.0% for the 3-month period (compared with (2.1)% in the prior-year period), and 23.3% for the 9-month period (compared with 123.7% in the prior-year period). It cited the tax impact of non-deductible goodwill impairments in the prior year as a factor in the change.
The company said that as of September 27, 2024, it had cash and cash equivalents of $1,185 million and debt of $4.7 billion, and that it had no borrowings under its revolving credit facility. During the 9-month period, it paid dividends of $155 million and made stock repurchases of $450 million.
Key figures
Quarter ended September 27, 2024
- Revenue
- $4.2B
- Operating income
- $516M
- Net income
- $364M
- EPS
- $2.68
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q3 2024 and 9-Month Net Bookings
The company said net bookings were approximately $8.1 billion and $15.8 billion for the 3-month and 9-month periods ended September 27, 2024, compared with $7.9 billion and $13.8 billion in the prior-year periods.
Source · Based on the MD&A text of the filing
Commercial & International Operating Income Increase Explained
The company cited an increase in operating income for Commercial & International over the 3 months, attributing it to the impairment charges of $679 million recorded in the prior year. For the 9-month period, it also cited the same impairment charges, program wins and a net increase in volumes, and said these were partially offset by write-downs on certain programs within its UK operations.
Source · Based on the MD&A text of the filing
Effective Tax Rate and Non-Operating Expense Changes
The company said its effective tax rate was 23.0% for the 3-month period (compared with (2.1)% in the prior-year period), and 23.3% for the 9-month period (compared with 123.7% in the prior-year period). It cited the tax impact of non-deductible goodwill impairments in the prior year as a factor in the change.
Source · Based on the MD&A text of the filing
Liquidity, Debt, Dividends and Share Repurchases
The company said that as of September 27, 2024, it had cash and cash equivalents of $1,185 million and debt of $4.7 billion, and that it had no borrowings under its revolving credit facility. During the 9-month period, it paid dividends of $155 million and made stock repurchases of $450 million.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…